The Role of Sentinel Node Biopsy is driven by Increased Accuracy in Cancer Detection

Comments · 39 Views

The global sentinel node biopsy market size is estimated to reach US$ 1,209.2 million by 2031 registering a CAGR of 7.0% over the forecast period.

Sentinel node biopsy is a minimally invasive surgical procedure used to determine if cancer has spread from its original site. In sentinel node biopsy, a blue dye and/or radioactive tracer is injected near the tumor to locate the first lymph node that would capture any spreading cancer cells from the original site. This first lymph node, known as the sentinel node, is then removed and examined.

Sentinel Node Biopsy Market Growth provides more accurate detection of cancer spreading compared to routine staging methods. It helps surgeons determine the extent of cancer spread and decide on the right treatment approach.

The growing prevalence of breast cancer and melanoma globally is propelling the demand for accurate staging procedures like sentinel node biopsy. According to the World Cancer Research Fund, breast cancer incidence has increased by more than 20% since 2012.

Get more insights on, Sentinel Node Biopsy Market

 

Explore More Related Article On- Medicinal Cannabis Market

 

Comments